Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0030193 (
pain
)
261,466
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Interstitial cystitis/bladder pain syndrome (IC) is a debilitating condition of chronic pelvic pain with unknown etiology. Recently, we used a genetic approach in a murine model of IC to identify the lipase
acyloxyacyl hydrolase
(
AOAH
) as a modulator of pelvic pain. We found that
AOAH
-deficient mice have elevated pelvic pain responses, and
AOAH
immunoreactivity was detected along the bladder-brain axis. Lipidomic analyses identified arachidonic acid (AA) and its metabolite PGE2 as significantly elevated in the sacral spinal cord of
AOAH
-deficient mice, suggesting AA is a substrate for
AOAH
. Here, we quantified the effects of
AOAH
on phospholipids containing AA. Spinal cord lipidomics revealed increased AA-containing phosphatidylcholine in
AOAH
-deficient mice and concomitantly decreased AA-phosphatidylethanolamine, consistent with decreased CoA-independent transferase activity (CoIT). Overexpression of
AOAH
in cell cultures similarly altered distribution of AA in phospholipid pools, promoted AA incorporation, and resulted in decreased membrane fluidity. Finally, administration of a PGE2 receptor antagonist reduced pelvic pain in
AOAH
-deficient mice. Together, these findings suggest that
AOAH
represents a potential CoA-independent AA transferase that modulates CNS
pain
pathways at the level of phospholipid metabolism.
...
PMID:AOAH remodels arachidonic acid-containing phospholipid pools in a model of interstitial cystitis pain: A MAPP Network study. 3292 15